Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach
- 1 November 2015
- journal article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 4 (6) , 515-520
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosisMultiple Sclerosis Journal, 2014
- No MRI evidence of cortical lesions in neuromyelitis opticaNeurology, 2012
- Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosisJournal of the Neurological Sciences, 2009
- Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis — A longitudinal voxel-based morphometry studyNeuroImage, 2009
- A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypesNeuroImage, 2008
- Localization of grey matter atrophy in early RRMSJournal of Neurology, 2006
- Longitudinal Diffusion Changes in Cerebral Hemispheres after MCA InfarctsJournal of Cerebral Blood Flow & Metabolism, 2005
- Occipito-temporal connections in the human brainBrain, 2003
- Aquaporins in Brain: Distribution, Physiology, and PathophysiologyJournal of Cerebral Blood Flow & Metabolism, 2002
- The distribution of plaques in the cerebrum in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 1962